Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis - Related Studies

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

This study has been completed.

Study NCT00001797. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Psoriasis

2	More general conditions related to this trial
		Skin Diseases
		Skin Diseases, Papulosquamous

3	Interventions listed in this trial
		Recombinant human interleukin-10

4	Sponsors listed in this trial
		National Cancer Institute (NCI)